Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propylene glycol + hydroxypropyl-guar is a combination used primarily as an ocular lubricant in artificial tear formulations for the management of dry eye disease. Propylene glycol acts as a demulcent and lubricant, providing moisture and protection to the ocular surface, while hydroxypropyl-guar (HP-guar), a derivative of guar gum, functions as a gelling agent that forms a protective matrix on the corneal surface. This matrix enhances retention time and stabilizes the tear film by conforming to irregularities on the ocular surface. The combination improves hydration, reduces friction, and protects against desiccation-induced damage. It is commonly found in preservative-free artificial tears for moderate-to-severe dry eye symptoms[4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propylene glycol + hydroxypropyl-guar.